1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > Kidney Transplantation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017


DelveInsight’s Report, “Kidney Transplantation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Kidney Transplantation Report is to understand the market and pipeline status of the drugs around the Kidney Transplantation to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Kidney Transplantation. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 48-72 Hours to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE:
- A snapshot of the global Market and Phase III therapeutics scenario for Kidney Transplantation.
- A review of the marketed products under prescription for Kidney Transplantation, regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
- Product profiles for marketed products for Kidney Transplantation with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
- Coverage of API Manufacturers for Kidney Transplantation drugs in the United States, Europe and Asian Regions with location details.
- Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Kidney Transplantation drugs.
- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Kidney Transplantation drugs.
- Coverage of Kidney Transplantation Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
- Key discontinued Marketed products.
- Global Sales Figure to 2018.

Reasons to buy:
- Evaluate the marketing status and exclusivity details of Kidney Transplantation key products to exploit opportunities for generic drug development opportunities.
- Identify and understand important and diverse types of therapeutics under Phase III development for Kidney Transplantation.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Kidney Transplantation.
- API intelligence over marketed drugs forKidney Transplantationand gaining primary intelligence over active ingredients manufacturers across the globe.
- API intelligence over leading Phase III Pipeline drugs.
- Develop and designstrategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.
- Understanding the scope of the Phase III Drugs with nil regulatory filings.
- Understanding the chemical route of synthesis of approved drugs for Kidney Transplantation.
- Uncovering opportunities in the rapidly growing US market.

Table Of Contents

Kidney Transplantation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
Illustrative
1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Kidney Transplantation
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Kidney Transplantation
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Kidney Transplantation
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer


List of Tables

- Kidney Transplantation Therapeutic Market, US, Marketed Drugs by Application Type, 2017
- Kidney Transplantation Therapeutic Market, US, Marketed Drugs by Marketing Status, 2017
- Kidney Transplantation Therapeutic Market, US, (Year), 2017
- Kidney Transplantation Marketed Drugs, API Manufacturers by US DMF Status, 2017
- Kidney Transplantation Marketed Drugs, US DMF Status Drug Specific (Number), 2017
- Kidney Transplantation Drugs, API Manufacturers, Europe by Country, 2017
- Kidney Transplantation Drugs, API Manufacturers, India by State, 2017
- Kidney Transplantation Drugs, API Manufacturers, China by Province, 2017
- Kidney Transplantation Drugs, API Manufacturers by Geography 2017
- Kidney Transplantation Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017
- Kidney Transplantation Therapeutic Market, Global Sales-2018 (in million USD)
- API Manufacturers for Drug, 2017
- Phase III Drugs for Kidney Transplantation, 2017
- Discontinued Drugs for Kidney Transplantation, 2017


List of Figures

- Kidney Transplantation Therapeutic Market, US, Marketed Drugs by Application Type (%), 2017
- Kidney Transplantation Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2017
- Kidney Transplantation Therapeutic Market, US, (Year), 2017
- Kidney Transplantation Marketed Drugs, API Manufacturers by US DMF Status (%), 2017
- Kidney Transplantation Marketed Drugs, US DMF Status Drug Specific (Number), 2017
- Kidney Transplantation Drugs, API Manufacturers, Europe by Country, 2017
- Kidney Transplantation Drugs, API Manufacturers, India by State, 2017
- Kidney Transplantation Drugs, API Manufacturers, China by Province, 2017
- Kidney Transplantation Drugs, API Manufacturers by Geography 2017
- Kidney Transplantation Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017
- Kidney Transplantation Therapeutic Market, Global Sales 2018 (in million USD)
- Drug, Patent/Exclusivity Expiry (Year), 2017

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
EU5 Ultrasound Systems Market Outlook to 2022

EU5 Ultrasound Systems Market Outlook to 2022

  • $ 5995
  • Industry report
  • February 2017
  • by GlobalData

EU5 Ultrasound Systems Market Outlook to 2022 Summary GlobalData’s new report, "EU5 Ultrasound Systems Market Outlook to 2022", provides key market data on the EU5 Ultrasound Systems market. The report ...

North America Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022

North America Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022

  • $ 5995
  • Industry report
  • February 2017
  • by GlobalData

North America Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022 Summary GlobalData’s new report, "North America Magnetic Resonance Imaging (MRI) Systems Market Outlook to 2022", provides ...

Knee Implant Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Knee Implant Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • February 2017
  • by Transparency Market Research

U.S. Knee Implant Market: Overview This report on knee implant market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries ...


Download Unlimited Documents from Trusted Public Sources

Cardiovascular Disease Statistics in the US

  • March 2017
    11 pages
  • Cardiovascular ...  

    Prosthesis  

    Surgery  

  • United States  

View report >

Prosthesis Industry in Switzerland and Europe

  • February 2017
    12 pages
  • Prosthesis  

  • Switzerland  

View report >

Health Care Provider Industry in the US

  • February 2017
    264 pages
  • Health Care Pro...  

    Digestive Syste...  

    Mammography Equ...  

  • United States  

    North America  

View report >

Prosthesis Industry

4 months ago

Related Market Segments :

Prosthesis
Cloud Computing

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.